The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
Open accessAbstract
Background and aims Diabetes mellitus is associated with poor prognosis in patients with COVID-19. On the other hand, COVID-19 contributes to worsening of dysglycemia in people with diabetes mellitus over and above that contributed by stress hyperglycemia. Herein, we have reviewed the two-way interactions between COVID-19 and diabetes mellitus. Methods We have performed an extensive literature search for articles in PubMed, EMBASE and Google Scholar databases till April 25, 2020, with the following keywords: “COVID-19”, “SARS-CoV-2”, “diabetes”, “diabetes mellitus”, “SARS”, “infection” and “management of diabetes mellitus” with interposition of the Boolean operator “AND”. Results Compromised innate immunity, pro-inflammatory cytokine milieu, reduced expression of ACE2 and use of renin-angiotensin-aldosterone system antagonists in people with diabetes mellitus contribute to poor prognosis in COVID-19. On the contrary, direct β-cell damage, cytokine-induced insulin resistance, hypokalemia and drugs used in the treatment of COVID-19 (like corticosteroids, lopinavir/ritonavir) can contribute to worsening of glucose control in people with diabetes mellitus. Conclusions The two-way interaction between COVID-19 and diabetes mellitus sets up a vicious cycle wherein COVID-19 leads to worsening of dysglycemia and diabetes mellitus, in turn, exacerbates the severity of COVID-19. Thus, it is imperative that people with diabetes mellitus take all necessary precautions and ensure good glycemic control amid the ongoing pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedWu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Diabetes is a risk factor for the progression and prognosis of COVID‐19
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3319 · Cited by 1,404
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K. D., Convalescent Plasma Study Group, Nguyen-Van-Tam, J. S., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 983
Huang, I., Lim, M. A., & Pranata, R. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.018 · Cited by 933
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Singh, A. K., Gupta, R., Ghosh, A., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.004 · Cited by 893
COVID-19 and diabetes: Knowledge in progress
Hussain, A., Bhowmik, B., & do Vale Moreira, N. C. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108142 · Cited by 796
Yang, J. K., Feng, Y., Yuan, M. Y., Yuan, S. Y., Fu, H. J., Wu, B. Y., Sun, G. Z., Yang, G. R., Zhang, X. L., Wang, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01861.x · Cited by 794
Tikellis, C., & Thomas, M. C. (2012) · International Journal of Peptides · doi:10.1155/2012/256294 · Cited by 624
Prevalence and impact of diabetes among people infected with SARS-CoV-2
Fadini, G. P., Morieri, M. L., Longato, E., & Avogaro, A. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01236-2 · Cited by 549
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
Gupta, R., Ghosh, A., Singh, A. K., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.002 · Cited by 518
Type 1 interferons as a potential treatment against COVID-19
Sallard, E., Lescure, F.-X., Yazdanpanah, Y., Mentre, F., & Peiffer-Smadja, N. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104791 · Cited by 509
Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.011 · Cited by 488
The Effect of Short-Term Hyperglycemia on the Innate Immune System
Jafar, N., Edriss, H., & Nugent, K. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2015.11.011 · Cited by 463
Risk of COVID‐19 for patients with obesity
Kassir, R. (2020) · Obesity Reviews · doi:10.1111/obr.13034 · Cited by 423
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4594 · Cited by 401
Diabetes mellitus and electrolyte disorders
Liamis, G. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i10.488 · Cited by 399
COVID-19, diabetes mellitus and ACE2: The conundrum
Pal, R., & Bhansali, A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108132 · Cited by 349
Self-citationAnalysis of Association between Vitamin D Deficiency and Insulin Resistance
Szymczak-Pajor, I., & Śliwińska, A. (2019) · Nutrients · doi:10.3390/nu11040794 · Cited by 335
wenzhong, L., & hualan, L. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11938173.v7 · Cited by 244
Ghosh, A., Gupta, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.001 · Cited by 236
Diabetes self-management amid COVID-19 pandemic
Banerjee, M., Chakraborty, S., & Pal, R. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.013 · Cited by 226
Self-citationThe COVID-19 Pandemic in the US: A Clinical Update
Omer, S. B., Malani, P., & del Rio, C. (2020) · JAMA · doi:10.1001/jama.2020.5788 · Cited by 209
Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID‐19 Pandemic
Carter, S. J., Baranauskas, M. N., & Fly, A. D. (2020) · Obesity · doi:10.1002/oby.22838 · Cited by 183
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
Pal, R., & Bhadada, S. K. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108146 · Cited by 164
Self-citationZhou, J., & Tan, J. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154216 · Cited by 137
Chou, H., Wang, J., Chang, C., Lee, J., Shau, W., & Lai, M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit439 · Cited by 134
Cüre, E., & Cüre, M. C. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.019 · Cited by 126
COVID-19 and non-communicable diseases
Pal, R., & Bhadada, S. K. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137742 · Cited by 102
Self-citationHage, M. P., Al-Badri, M. R., & Azar, S. T. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814547204 · Cited by 98
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans
Iqbal, A., Prince, L. R., Novodvorský, P., Bernjak, A., Thomas, M. R., Birch, L., Lambert, D., Kay, L. J., Wright, F., Macdonald, I. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01168 · Cited by 97
Type 2 Diabetes: An Atherothrombotic Syndrome
Dunn, E., & Grant, P. J. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766059 · Cited by 92
Xue, T., Li, Q., Zhang, Q., Lin, W., Wen, J., Li, L., & Chen, G. (2020) · SSRN Electronic Journal · doi:10.1101/2020.03.31.20048579 · Cited by 89
Type 1 Diabetes and Interferon Therapy
Nakamura, K., Kawasaki, E., Imagawa, A., Awata, T., Ikegami, H., Uchigata, Y., Kobayashi, T., Shimada, A., Nakanishi, K., Makino, H., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2274 · Cited by 68
Hoffman, E., Rahat, M. A., Feld, J., Elias, M., Rosner, I., Kaly, L., Lavie, I., Gazitt, T., & Zisman, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184633 · Cited by 65
Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., Kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196368 · Cited by 64
Wan, J., Sun, W., Li, X., Ying, W., Dai, J., Kuai, X., Wei, H., Gao, X., Zhu, Y., Jiang, Y. Z., et al. (2006) · PROTEOMICS · doi:10.1002/pmic.200500638 · Cited by 60
Epperla, N., & McKiernan, F. (2015) · SpringerPlus · doi:10.1186/s40064-015-1218-x · Cited by 38
Cited by
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 532
Kompaniyets, L., Pennington, A. F., Goodman, A. B., Rosenblum, H. G., Belay, B., Ko, J. Y., Chevinsky, J. R., Schieber, L. Z., Summers, A. D., Lavery, A. M., et al. (2021) · Preventing Chronic Disease · doi:10.5888/pcd18.210123 · Cited by 372
Mansfield, K. E., Mathur, R., Tazare, J., Henderson, A. D., Mulick, A. R., Carreira, H., Matthews, A. A., Bidulka, P., Gayle, A., Forbes, H., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00017-0 · Cited by 338
COVID‐19‐associated mucormycosis: An updated systematic review of literature
Pal, R., Singh, B., Bhadada, S. K., Banerjee, M., Bhogal, R. S., Hage, N., & Kumar, A. (2021) · Mycoses · doi:10.1111/myc.13338 · Cited by 289
Self-citationYin, W., Liu, Y., Hu, H., Sun, J., Liu, Y., & Wang, Z. (2022) · PLOS ONE · doi:10.1371/journal.pone.0275251 · Cited by 27
Metadata
- Authors
- Pal, R., & Bhadada, S. K.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 14
- Issue
- 4
- Pages
- 513-517
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W3022957048
- Cited by
- 299
- References
- 43
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.